Assessment and improvement of liver specific function of the AMC-bioartificial liver

International Journal of Artificial Organs

Volumn 28, Issue 6, 2005, Pages 617-630

  Van De Kerkhove, M P ^a   Poyck, P P C ^a   Van Wijk, A C W A ^a   Galavotti, D ^b   Hoekstra, R ^a   Van Gulik, T M ^a   Chamuleau, R A F M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RanD SrI   (Italy)

Author keywords

Bioactive mass; Bioartificial liver; Function; Hepatocyte; Liver failure; Porcine

Indexed keywords

AMMONIA; BIOCONVERSION; BIOREACTORS; PATIENT TREATMENT;

ASSESSMENT AND IMPROVEMENT; BIOACTIVE MASS; BIOACTIVES; BIOARTIFICIAL LIVER; HEPATOCYTES; LIVER FAILURE; LIVER FUNCTIONS; LIVER-SPECIFIC FUNCTIONS; PORCINE; QUANTIFICATION METHODS;

ARTIFICIAL ORGANS;

AMMONIA; ASPARTATE AMINOTRANSFERASE; GLUCOSE; LACTATE DEHYDROGENASE; LACTIC ACID; LIDOCAINE; OXIDOREDUCTASE; OXYGEN; POLYCARBONATE; POLYSULFONE; UREA;

AMMONIA FORMATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL LIVER; BIOARTIFICIAL ORGAN; BIOREACTOR; CELL ISOLATION; CONSENSUS; DRUG ELIMINATION; LABORATORY TEST; LIVER CELL; LIVER FAILURE; LIVER FUNCTION; METABOLIC PARAMETERS; NONHUMAN; OXYGEN CONSUMPTION; RELIABILITY; SWINE;

EID: 23144446971     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880502800611     Document Type: Article

References (24)

1. United Network for Organ Sharing. Liver transplantation data 2002; www.unos.org. 2002.
2. Van de Kerkhove MP, Hoekstra R, Chamuleau RA, van Gulik TM. Clinical application of bioartificial liver support systems. Ann Surg 2004; 240: 216-30.
3. Flendrig LM, te Velde AA, Chamuleau RA. Semipermeable hollow fiber membranes in hepatocyte bioreactors: A prerequisite for a successful bioartificial liver? Artif Organs 1997; 21: 1177-81.
4. Flendrig LM, la Soe JW, Jorning GG, Steenbeek A, Karlsen OT, Bovee, et al. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J Hepatol 1997; 26: 1379-92.
5. Flendrig LM, Sommeijer D, Ladiges NC, te Velde AA, Maas MA, Jorning, et al. Commercially available media for flushing extracorporeal bioartificial liver systems prior to connection to the patient's circulation: An in vitro comparative study in two and three dimensional porcine hepatocyte cultures. Int J Artif Organs 1998; 21: 467-72.
6. Flendrig LM, Maas MA, Daalhuisen J, Ladiges NC, La Soe JW, Te Velde AA, et al. Does the extend of the culture time of primary hepatocytes in a bioreactor affect the treatment efficacy of a bioartificial liver? Int J Artif Organs 1998; 21: 542-7.
7. Flendrig LM. Development of a novel bioarticial liver. Academic Medical Center, University of Amsterdam, 1998.
8. Flendrig LM, Chamuleau RA, Maas MA, Daalhuisen J, Hasset B, Kilty CG, et al. Evaluation of a novel bioartificial liver in rats with complete liver ischemia: Treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability. J Hepatol 1999; 30: 311-20.
9. Flendrig LM, Calise F, Di Florio E, Mancini A, Ceriello A, Santaniello W, et al. Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. Int J Artif Organs 1999; 22: 701-9.
10. Sosef MN, Abrahamse LS, van de Kerkhove MP, Hartman R, Chamuleau RA, van Gulik TM. Assessment of the AMC-bioartificial liver in the anhepatic pig. Transplantation 2002; 73: 204-9.
11. Abrahamse SL, van de Kerkhove MP, Sosef MN, Hartman R, Chamuleau RA, van Gulik TM. Treatment of acute liver failure in pigs reduces hepatocyte function in a bioartificial liver support system. Int J Artif Organs 2002; 25: 966-74.
12. Sosef MN, van de Kerkhove MP, Abrahamse LS, Levi M, Chamuleau RA, van Gulik TM. Blood coagulation in anhepatic pigs: Effects of treatment with the AMC bioartificial liver. J Thromb Haemost 2003; 1: 511-5.
13. Van de Kerkhove MP, Di Florio E, Scuderi V, Mancini A, Belli A, Bracco A, et al. Bridging a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver. Cell Transplant 2003; 12: 563-8.
14. Van de Kerkhove MP, Di Florio E, Scuderi V, Mancini A, Belli A, Bracco A, et al. Phase I clinical trial with the AMC-bioartificial liver. Int J Artif Organs 2002; 25: 950-9.
15. te Velde AA, Ladiges NC, Flendrig LM, Chamuleau RA. Functional activity of isolated pig hepatocytes attached to different extracellular matrix substrates. Implication for application of pig hepatocytes in a bioartificial liver. J Hepatol 1995; 23: 184-92.
16. De Bartolo L, Jarosch-Von Schweder G, Haverich A, Bader A. A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: Cell viability and tissue-specific functions. Biotechnol Prog 2000; 16: 102-8.
17. Katsura N, Ikai I, Mitaka T, Shiotani T, Yamanokuchi S, Sugimoto S, et al. Long-term culture of primary human hepatocytes with preservation of proliferative capacity and differentiated functions. J Surg Res 2002; 106: 115-23.
18. DeMatteo RP, Fong Y, Blumgart LH. Surgical treatment of malignant liver tumours. Baillieres Best Pract Res Clin Gastroenterol 1999; 13: 557-74.
19. McCarter MD, Fong Y. Metastatic liver tumors. Semin Surg Oncol 2000; 19: 177-88.
20. Greengard O, Federman M, Knox WE. Cytomorphometry of developing rat liver and its application to enzymic differentiation. J Cell Biol 1972; 52: 261-72.
21. Weibel ER, Staubli W, Gnagi HR, Hess FA. Correlated morphometric and biochemical studies on the liver cell. I. Morphometric model, stereologic methods, and normal morphometric data for rat liver. J Cell Biol 1969; 42: 68-91.
22. Berry MN, Edwards AM, Barritt GJ. Isolated hepatocytes preparation, properties and applications. In: Burdon RH and van Knippenberg PH, eds. Laboratory techniques in biochemistry and molecular biology. Amsterdam: Elsevier, 1991.
23. Morsiani E, Brogli M, Galavotti D, Pazzi P, Puviani AC, Azzena GF. Biologic liver support: Optimal cell source and mass. Int J Artif Organs 2002; 25: 985-93.
24. Baker TK, Carfagna MA, Gao H, Dow ER, Li Q, Searfoss GH et al. Temporal gene expression analysis of monolayer cultured rat hepatocytes. Chem Res Toxicol 2001; 14: 1218-31.